Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors

World Neurosurgery
Ramesh GrandhiAndrew F Ducruet

Abstract

Direct factor Xa inhibitors rivaroxaban and apixaban are efficacious alternatives to warfarin and confer a lower risk of spontaneous intracranial hemorrhage (ICH); however, they lack a validated reversal strategy. We evaluated the efficacy and safety of 4-factor prothrombin complex concentrate (PCC) administration on rivaroxaban- and apixaban-mediated coagulopathy in patients with traumatic and spontaneous ICH. Retrospective review of patients presenting with traumatic and spontaneous ICH and concurrent use of rivaroxaban or apixaban. Demographic factors, reason for anticoagulation, hemorrhage type and location, Glasgow coma scale score, and when appropriate, ICH score, were included. Patient charts were reviewed for in-hospital mortality, thromboembolic events, pulmonary complications, worsening of hemorrhage, hemorrhagic complications after neurosurgical intervention, and 90-day modified Rankin scale score. Eighteen patients met inclusion criteria; 16 used rivaroxaban and 2 used apixaban. Eight patients presented with traumatic ICH, 8 with hemorrhagic stroke, 1 with subarachnoid hemorrhage, and 1 patient with tumoral hemorrhage. Mean Glasgow coma scale score was 12.6 (range, 6-15) and mean ICH score was 2.3 (range, 0-4). Afte...Continue Reading

References

Jun 27, 2008·The New England Journal of Medicine·Bengt I ErikssonUNKNOWN RECORD1 Study Group
Jun 27, 2008·The New England Journal of Medicine·Michael R LassenUNKNOWN RECORD3 Investigators
Aug 12, 2008·International Journal of Clinical Practice·U KalinaS Schulte
Aug 7, 2009·The New England Journal of Medicine·Michael Rud LassenRonald J Portman
Dec 7, 2010·The New England Journal of Medicine·Rupert BauersachsSebastian Schellong
Dec 24, 2010·The New England Journal of Medicine·Michael Rud LassenUNKNOWN ADVANCE-3 Investigators
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Mar 28, 2012·The New England Journal of Medicine·Harry R BüllerAnnelise Segers
Apr 5, 2012·American Journal of Hematology·Scott KaatzJack Ansell
Dec 12, 2012·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN AMPLIFY-EXT Investigators
May 15, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·T SteinerR Veltkamp
Jun 29, 2013·Critical Care : the Official Journal of the Critical Care Forum·Alejandro Lazo-LangnerJames Douketis
Jul 3, 2013·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN AMPLIFY Investigators
Jul 4, 2013·Cleveland Clinic Journal of Medicine·Adewale FawoleMark A Crowther
Aug 20, 2014·BioMed Research International·Lisa M Baumann KreuzigerDavid J Dries

❮ Previous
Next ❯

Citations

May 8, 2016·Neurologia i neurochirurgia polska·Claudia Stöllberger, Josef Finsterer
Apr 14, 2016·Thrombosis Research·Sam SchulmanAmmar Majeed
May 18, 2016·American Journal of Surgery·Brian K Yorkgitis
Sep 3, 2016·The American Journal of Medicine·John Eikelboom, Geno Merli
Oct 5, 2016·The American Journal of Emergency Medicine·John Eikelboom, Geno Merli
Jan 21, 2016·Journal of Pharmacy Practice·Andrew C FaustTina Harrach Denetclaw
Jul 21, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Masahiro YasakaKazunori Toyoda
Oct 13, 2018·Blood·Beverley J HuntJakob Stensballe
May 6, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·William Dager, Thaddaus Hellwig
Apr 13, 2019·Expert Opinion on Biological Therapy·J FavresseF Mullier
Apr 16, 2019·Journal of Intensive Care Medicine·Karen BergerChristine A Lesch
Jun 3, 2016·Current Opinion in Critical Care·Charles Marc Samama
Mar 2, 2018·Critical Care Nursing Quarterly·Nicholas Farina, James T Miller
Nov 15, 2019·Critical Pathways in Cardiology·Kent A OwusuAlfred Ian Lee
Apr 9, 2020·Circulation·Nicholas G PanosUNKNOWN Neurocritical Care Society (NCS) Pharmacy Study Group
Oct 18, 2019·Medicines·Stephanie A Kustos, Pius S Fasinu
Jul 22, 2020·Drugs·R Monroe Crawley, Rachel L Anderson
Jun 3, 2017·Neurocritical Care·Jonathan MarehbianDavid Y Hwang
Jun 11, 2019·International Journal of Emergency Medicine·Maureane HoffmanJerrold H Levy
May 24, 2021·Journal of Thrombosis and Thrombolysis·Ioannis MilioglouMaria Papaioannou
Jun 8, 2021·Journal of Thrombosis and Thrombolysis·Gabrielle L ProcopioKeri Bicking
Jun 5, 2021·Research and Practice in Thrombosis and Haemostasis·Tessa JaspersNakisa Khorsand
Jun 19, 2021·Journal of the American College of Cardiology·Antonio Gómez-OutesEmilio Vargas-Castrillón
Sep 21, 2021·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Victoria M StevensScott W Mueller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.